NuSkin Enterprises NUS Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 69.3%-0.1pp | 69.4%+2.2pp | 67.2%0.0pp | 67.2%-0.3pp | 67.6%-0.7pp | |
| Operating margin | 5.5%+1.1pp | 4.4%+5.1pp | -0.7%+0.2pp | -0.9%+9.3pp | -10.1%-1.4pp | |
| Net margin | 3.8%-7.0pp | 10.8%+3.8pp | 7%+0.8pp | 6.2%+8.5pp | -2.3%+6.2pp | |
| Returns | ||||||
| Return on equity | 7%-15.0pp | 22%+7.4pp | 14.5%+0.9pp | 13.7%+18.6pp | -4.9%+15.0pp | |
| Return on invested capital | 7.6%+1.7pp | 5.9%+6.9pp | -1%+0.2pp | -1.3%+15.2pp | -16.5%-2.2pp | |
| Efficiency | ||||||
| Asset turnover | 1×0.0× | 1×0.0× | 1×0.0× | 1.1×0.0× | 1.1×0.0× | |
| Liquidity | ||||||
| Current ratio | 2×0.0× | 2.1×-0.1× | 2.2×+0.1× | 2×0.0× | 2×+0.2× | |
| Leverage | ||||||
| Debt-to-equity | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×0.0× | 0.4×-0.3× | |
| Net debt / EBITDA | 0.8×— | —— | —— | —— | —— | |
| Per Share | ||||||
| Book value per share | $16.07+0.4% | $16.01+0.7% | $15.90-0.1% | $15.91+6.2% | $14.98+14.2% | |
| Valuation | ||||||
| Market capitalization | $256.35M-38.2% | $468.98M-22.3% | $603.38M+57.4% | $383.44M+6.2% | $360.99M+5.4% | |
| Price / earnings | 4.5×+0.6× | —— | —— | —— | —— | |
| Price / sales | 0.2×-0.1× | 0.3×-0.1× | 0.4×+0.2× | 0.2×0.0× | 0.2×0.0× | |
| Price / book | 0.3×-0.2× | 0.6×-0.2× | 0.8×+0.3× | 0.5×0.0× | 0.5×0.0× | |
| EV / EBITDA | 2.7×-7.3× | —— | —— | —— | —— | |
| Dividend yield | 4.8%+1.8pp | 2.5%+0.5pp | 2%-1.1pp | 3.1%-0.2pp | 3.3%-0.2pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do NuSkin Enterprises's ratios come from?
- Every ratio is computed from NuSkin Enterprises's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.